| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.21B | 1.39B | 1.54B | 1.38B | 1.63B |
| Gross Profit | 726.97M | 786.89M | 871.44M | 767.06M | 943.29M |
| EBITDA | 4.60M | 26.11M | 55.71M | 98.42M | 28.96M |
| Net Income | -150.04M | 48.25M | 20.83M | 14.79M | 27.35M |
Balance Sheet | |||||
| Total Assets | 1.40B | 1.48B | 1.75B | 1.72B | 1.75B |
| Cash, Cash Equivalents and Short-Term Investments | 561.61M | 429.75M | 663.46M | 496.25M | 443.12M |
| Total Debt | 23.89M | 19.37M | 21.24M | 44.63M | 54.94M |
| Total Liabilities | 293.59M | 296.10M | 357.66M | 344.55M | 391.06M |
| Stockholders Equity | 1.10B | 1.18B | 1.38B | 1.36B | 1.35B |
Cash Flow | |||||
| Free Cash Flow | 118.88M | 23.50M | 177.59M | 101.46M | -78.92M |
| Operating Cash Flow | 147.30M | 107.80M | 238.99M | 174.74M | 31.22M |
| Investing Cash Flow | -79.28M | -74.04M | -43.80M | -91.27M | -100.03M |
| Financing Cash Flow | 60.19M | -267.47M | -27.98M | -30.34M | -34.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | HK$771.65M | 7.11 | 16.16% | 4.60% | 12.73% | 9.25% | |
76 Outperform | HK$11.03B | 8.60 | 12.93% | 5.22% | 10.65% | 13.67% | |
74 Outperform | HK$11.50B | 11.78 | 9.07% | 10.16% | 1.53% | -21.76% | |
66 Neutral | HK$23.07B | 22.15 | 9.61% | 7.69% | -1.93% | -1.36% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | HK$2.39B | -8.93 | -14.13% | ― | -12.84% | -405.56% | |
46 Neutral | HK$229.27M | -1.26 | -20.20% | ― | -30.43% | -97.13% |